OR17-4 Transcon Growth Hormone In The Treatment Of Pediatric Growth Hormone Deficiency: Results Of The Phase 3 Height Trial

TransCon Growth Hormone in the Treatment of Pediatric Growth Hormone Deficiency: Results of the Phase 3 heiGHt Trial Background TransCon Growth Hormone is a sustained-release recombinant human growth hormone (hGH; somatropin) prodrug in development as a long-acting GH (LAGH) for children with growth...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Endocr Soc
Main Authors: Thornton, Paul, Hofman, Paul, Maniatis, Aristides, Aghajanova, Elena, Chertok, Elena, Korpal-Szczyrska, Maria, Giorgadze, Elene, Kovalenko, Tatiana, Shu, Aimee, Karpf, David, Beckert, Michael, Leff, Jonathan
Formato: Artigo
Idioma:Inglês
Publicado: Endocrine Society 2019
Assuntos:
Pediatric Endocrinology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6554858/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-OR17-4
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares